In addition to the widely studied antiviral function of the IFITMs, IFITM1 and IFITM3 also function as a pro-oncogenic protein for which the expression has been reported in various cancers such as breast, cervix, colon, leukemia, ovary, brain, and esophagus [18,33,34,35,36,37,38,39,40]. This evidence concerns the gene IFITM1 and cancer.